A E Ryan
Overview
Explore the profile of A E Ryan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
168
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Swan D, Henderson R, McEllistrim C, Naicker S, Quinn J, Cahill M, et al.
Clin Lymphoma Myeloma Leuk
. 2022 Aug;
22(11):847-852.
PMID: 35985959
The phase 1b 16-BCNI-001/CTRIAL-IE 16-02 CyBorD-DARA trial investigated the combination of Daratumumab with cyclophosphamide, bortezomib and dexamethasone in patients with newly diagnosed multiple myeloma (NDMM), followed by autologous stem cell...
2.
ODwyer M, Henderson R, Naicker S, Cahill M, Murphy P, Mykytiv V, et al.
Blood Adv
. 2019 Jun;
3(12):1815-1825.
PMID: 31201169
Daratumumab (DARA) has shown impressive activity in combination with other agents for the treatment of multiple myeloma (MM). We conducted a phase 1b study to assess the safety and preliminary...
3.
Lohan P, Treacy O, Lynch K, Barry F, Murphy M, Griffin M, et al.
Osteoarthritis Cartilage
. 2015 Oct;
24(3):521-33.
PMID: 26493330
Objective: Allogeneic cell therapies, such as mesenchymal stromal cells (MSC), which have potent regenerative and anti-inflammatory potential are being investigated as a therapy for osteoarthritis (OA) and cartilage injury. Here...
4.
Oleary L, van der Sloot A, Reis C, Deegan S, Ryan A, Dhami S, et al.
Oncogene
. 2015 Jun;
35(10):1261-70.
PMID: 26050621
Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) is a death ligand cytokine known for its cytotoxic activity against malignantly transformed cells. TRAIL induces cell death through binding to death receptors DR4...
5.
Treacy O, OFlynn L, Ryan A, Morcos M, Lohan P, Schu S, et al.
Am J Transplant
. 2014 Oct;
14(9):2023-36.
PMID: 25307035
Mesenchymal stem cells (MSCs) are being investigated extensively due to their ability to dampen immune responses. Here, we tested the ability of MSCs from three distinct sources to prolong rat...
6.
Ryan A, Colleran A, OGorman A, OFlynn L, Pindjacova J, Lohan P, et al.
Oncogene
. 2014 Apr;
34(12):1563-74.
PMID: 24704833
In a model of peritoneal metastasis in immune-competent mice, we show that nuclear factor (NF)-κB inhibition in CT26 colon cancer cells prevents metastasis. NF-κB inhibition, by stable overexpression of IκB-α...
7.
Puliaev R, Puliaeva I, Ryan A, Via C
Curr Med Chem Immunol Endocr Metab Agents
. 2009 Oct;
5(6):575-583.
PMID: 19865585
Since its description roughly 30 years ago, the parent-into-F1 model of graft-vs.-host disease has provided insights into the mechanisms of in vivo T cell activation and the pathogenesis of autoimmune...
8.
9.
10.
Boreham R, McCowan M, Ryan A, Allworth A, Robson J
Pathology
. 1995 Apr;
27(2):182-5.
PMID: 7567150
Trichostrongylus infection, an uncommonly reported zoonosis in Australia, is common in parts of the world where there is close human contact with herbivorous animals. We report 5 cases diagnosed in...